Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors

American Journal of Pathology

Volumn 153, Issue 2, 1998, Pages 395-403

  Lymboussaki, Athina ^a   Partanen, Taina A ^a   Olofsson, Birgitta ^a,b   Thomas Crusells, Judith ^a   Fletcher, Christopher D M ^c   De Waal, Robert M W ^d   Kaipainen, Arja ^a   Alitalo, Kari ^a,e  

^a UNIVERSITY OF HELSINKI   (Finland)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; CELL LABELING; CONTROLLED STUDY; FETUS; HISTOCHEMISTRY; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; LYMPH VESSEL ENDOTHELIUM; PRIORITY JOURNAL; SKIN EPITHELIUM; TECHNIQUE; VASCULAR TUMOR;

EID: 0031876209     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65583-6     Document Type: Article

References (33)

1. Folkman J, Shing Y: Angiogenesis. J Biol Chem 1992, 267:10931-10934
2. Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996, 86:353-364
3. Ferrara N, Davis-Smyth T: The biology of vascular endothelial growth factor. Endocr Rev 1997, 18:4-25
4. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG: Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 1991, 88:9267-9271
5. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K: A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996, 15:290-298
6. Lee J, Gray A, Yuan J, Luoh S-M, Avraham H, Wood W: Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. Proc Natl Acad Sci USA 1996, 93:1988-1992
7. Achen MG, Jeltsch M, Kukk E, Mäkinen T, Vitali A, Wilks AF, Alitalo K, Stacker SA: Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 1998, 95:548-553
8. Olofsson B, Pajusola K, Kaipainen A, von Euler G, Joukov V, Saksela O, Orpana A, Pettersson RF, Alitalo K, Eriksson, U: Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA 1996, 93:2576-2581
9. Yamada Y, Nezu J, Shimane M, Hirata Y: Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Genomics 1997, 42:483-488
10. de Vries C, Escobedo J, Ueno H, Houck H, Ferrara N, Williams L: The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992, 255:989-991
11. Matthews W, Jordan C, Gavin M, Jenkins N, Copeland N, Lemischka I: A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc Natl Acad Sci USA 1991, 88:9026-9030
12. Pajusola K, Aprelikova O, Korhonen J, Kaipainen A, Pertovaara L, Alitalo R, Alitalo K: FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res 1993, 52:5738-5743
13. Quinn T, Peters K, de Vries C, Ferrara N, Williams L: Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci USA 1993, 90:7533-7537
14. Shibuya M: Role of VEGF-flt receptor system in normal and tumor angiogenesis. Adv Cancer Res 1995, 67:281-316.
15. Terman B, Dougher-Vermazen M, Carrion M, Dimitrov D, Armellino D, Gospodarowich D, Bohlen P: Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 1992, 187:1579-1586
16. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain R, Alitalo K: Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 1997, 276:1423-1425
17. Oh S, Jeltsch M, Birkenhäger R, McCarthy J, Weich H, Christ B, Alitalo K, Wilting J: VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol 1997, 188:96-109
18. Munsick R: Human fetal extremity lengths in the interval from 9 to 21 menstrual weeks of pregnancy. Am J Obstet Gynecol 1984, 149:883-887
19. Kaipainen A, Korhonen J, Pajusola K, Aprelikova O, Persico M, Terman B, Alitalo K: The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells. J Exp Med 1993, 178:2077-2088
20. Joukov V, Sorsa T, Kumar V, Jeltsch M, Claesson-Welsh L, Cao Y, Saksela O, Kalkkinen N, Alitalo K: Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J 1997, 13:3898-3911
21. Gomez CS, Calonje E, Ferrar D, Browse N, Fletcher CDM: Lymphangiomatosis of the limbs. Am J Surg Pathol 1995, 2:125-133
22. Jussila L, Valtola R, Partanen TA, Salven P, Heikkilä P, Matikainen M-T, Renkonen R, Kaipainen A, Detmar M, Tschachler E, Alitalo R, Alitalo K: Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor 3. Cancer Res 1998 58:1599-1604
23. Kerstens H, Poddighe P, Hanselaar A: A novel in situ hybridization signal amplification method based on the deposition of biotinylated tyramine. J Histochem Cytochem 1995, 43:347-352
24. de Waal R, van Altena M, Erhard H, Weidle U, Nooijen P, Ruiter D: Lack of lymphangiogenesis in human primary cutaneous melanoma. Am J Pathol 1997, 150:1951-1957
25. Autio-Harmainen H, Karttunen T, Apaja-Sarkkinen M, Dammert K, Risteli L: Laminin and type IV collagen in different histological stages of Kaposi's sarcoma and other vascular lesions of blood vessel origin. Am J Surg Pathol 1988, 12:469-476
26. Lubach D, Wawrzyniak-Schulz A, Neukam D, Nissen S: The extension technique: a new method of demonstrating initial lymph vessels in excised human skin. Br J Dermatol 1990, 123:179-185
27. Kaipainen A, Korhonen J, Mustonen T, Van Hinsberg V, Fang G, Dumont D, Breitman M, Alitalo K: Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 1995, 92:3566-3570
28. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller N, Werner R, Ullrich A: High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993, 72:835-846
29. Breier G, Clauss M, Risau W: Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development. Dev Dyn 1995, 204:228-239
30. Peters K, De Vries C, Williams L: Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA 1993, 90:8915-8919
31. Peh W, Ngan H: Lymphography: still useful in the diagnosis of lymphangiomatosis. Br J Radiol 1993, 66:28-31
32. Ramani P, Shah A: Lymphangiomatosis. Am J Surg Pathol 1993; 17:329-335
33. Wade T, Kamino H, Ackerman A: A histologic atlas of vascular lesions. J Dermatol Surg Oncol 1978, 4:845-850